MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 108 filers reported holding MYOVANT SCIENCES LTD in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,280,816 | -99.9% | 47,508 | -17.1% | 0.00% | 0.0% |
| Q3 2022 | $1,029,198,000 | +207.2% | 57,305 | +112.6% | 0.00% | +100.0% |
| Q2 2022 | $335,013,000 | -65.3% | 26,952 | -62.8% | 0.00% | 0.0% |
| Q1 2022 | $965,820,000 | -28.2% | 72,509 | -16.1% | 0.00% | -50.0% |
| Q4 2021 | $1,344,921,000 | +699.1% | 86,379 | +1051.7% | 0.00% | – |
| Q3 2021 | $168,300,000 | -3.7% | 7,500 | -2.3% | 0.00% | – |
| Q2 2021 | $174,828,000 | +125.3% | 7,678 | +103.6% | 0.00% | – |
| Q1 2021 | $77,607,000 | +3205.2% | 3,771 | +4336.5% | 0.00% | – |
| Q4 2020 | $2,348,000 | +96.6% | 85 | 0.0% | 0.00% | – |
| Q3 2020 | $1,194,000 | +79.8% | 85 | -3.4% | 0.00% | – |
| Q1 2020 | $664,000 | -74.4% | 88 | -47.3% | 0.00% | – |
| Q4 2019 | $2,592,000 | +223.6% | 167 | +8.4% | 0.00% | – |
| Q3 2019 | $801,000 | -42.5% | 154 | 0.0% | 0.00% | – |
| Q2 2019 | $1,394,000 | -4.3% | 154 | +152.5% | 0.00% | – |
| Q1 2019 | $1,456,000 | +45.5% | 61 | 0.0% | 0.00% | – |
| Q4 2018 | $1,001,000 | -62.3% | 61 | -39.0% | 0.00% | – |
| Q3 2018 | $2,655,000 | +16.1% | 100 | 0.0% | 0.00% | – |
| Q2 2018 | $2,287,000 | +7.5% | 100 | 0.0% | 0.00% | – |
| Q1 2018 | $2,127,000 | +1019.5% | 100 | +566.7% | 0.00% | – |
| Q4 2017 | $190,000 | -18.1% | 15 | 0.0% | 0.00% | – |
| Q3 2017 | $232,000 | +31.8% | 15 | 0.0% | 0.00% | – |
| Q2 2017 | $176,000 | -67.4% | 15 | -67.4% | 0.00% | – |
| Q1 2017 | $540,000 | – | 46 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| VitalStone Financial, LLC | 15 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |